Loading…
Based on limited metadata, StemGenex Biologic Laboratories, LLC received an FDA Warning Letter on October 31, 2018, regarding biologics products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter was issued under FDA's biologics regulatory authority, which typically addresses concerns related to manufacturing, quality control, safety, or efficacy of biologic drug products.